BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17182694)

  • 1. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
    Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
    J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
    Ma J; Wollmann R; Lindquist S
    Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein.
    Asante EA; Linehan JM; Smidak M; Tomlinson A; Grimshaw A; Jeelani A; Jakubcova T; Hamdan S; Powell C; Brandner S; Wadsworth JD; Collinge J
    PLoS Pathog; 2013; 9(9):e1003643. PubMed ID: 24086135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
    Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
    J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.
    Supattapone S; Bosque P; Muramoto T; Wille H; Aagaard C; Peretz D; Nguyen HO; Heinrich C; Torchia M; Safar J; Cohen FE; DeArmond SJ; Prusiner SB; Scott M
    Cell; 1999 Mar; 96(6):869-78. PubMed ID: 10102274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
    Ma J; Lindquist S
    Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.
    Nishida N; Harris DA; Vilette D; Laude H; Frobert Y; Grassi J; Casanova D; Milhavet O; Lehmann S
    J Virol; 2000 Jan; 74(1):320-5. PubMed ID: 10590120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains.
    Korth C; Kaneko K; Prusiner SB
    J Gen Virol; 2000 Oct; 81(Pt 10):2555-2563. PubMed ID: 10993946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human prion protein inhibits prion propagation in vitro.
    Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
    Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
    Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
    Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
    Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z
    J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic Interference in Prion Replication Is Modulated by the Convertibility of the Interfering PrP
    Espinosa JC; Andreoletti O; Marín-Moreno A; Lugan S; Aguilar-Calvo P; Cassard H; Lorenzo P; Douet JY; Villa-Díaz A; Aron N; Prieto I; Huor A; Torres JM
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.